Science Explorer Back to mapMap
Discussion
Researcher · Institut Curie · France

Wilfrid Richer

Wilfrid Richer publishes mostly in Immunology, Molecular Biology and Oncology, on topics such as Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction and T-cell and B-cell Immunology.

ORCID 0000-0003-1802-3529 OpenAlex
World rank
#239,772
of 7,710,434 ranked researchers
Rank in France
#14,787
of 324,115
Works
72
Citations
3.5k
Citations per work
49.3
h-index
25
i10-index 31Top 21% in Immunology
Wilfrid Richer

What does Wilfrid Richer research?

Wilfrid Richer's work is mostly in Immunology and Microbiology (32%), Medicine (28%), Biochemistry, Genetics and Molecular Biology (19%).

Life Sciences: 37 works · 51.2% of their workImmunology and Microbiology: 23 works · 31.8% of their workImmunology: 23 works · 31.8% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 19.4% of their workMolecular Biology: 14 works · 19.4% of their workHealth Sciences: 20 works · 28.2% of their workMedicine: 20 works · 28.2% of their workOncology: 11 works · 14.7% of their workPathology and Forensic Medicine: 4 works · 5.9% of their workPulmonary and Respiratory Medicine: 3 works · 4.1% of their workNeurology: 3 works · 3.5% of their workEverything else: 15 works · 20.6% of their workTHEIR WORKWilfrid Richer72works
Life Sciences51%Health Sciences28%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology2331.8%
    2. Biochemistry, Genetics and Molecular Biology1419.4%
    1. Medicine2028.2%
  3. Everything else1520.6%
  1. 1Immunology32% of their works
  2. 2Molecular Biology19% of their works
  3. 3Oncology15% of their works
  4. 4Pathology and Forensic Medicine6% of their works
  5. 5Pulmonary and Respiratory Medicine4% of their works
  6. 6Neurology4% of their works

Research topics

Which keywords describe Wilfrid Richer's research?

The keywords of their largest research topics: Cancer, Immune Checkpoint Blockade, Immunity, Innate Immunity, PD-1 and PD-L1, Foxp3, Natural Killer Cells and NK Cell Recognition.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer192 topics
  2. Immune Checkpoint Blockade161 topic
  3. Immunity162 topics
  4. Innate Immunity162 topics
  5. PD-1 and PD-L1161 topic
  6. Foxp3151 topic
  7. NK Cell Recognition151 topic
  8. Natural Killer Cells151 topic
  9. TGF-ß151 topic
  10. Chromatin Remodeling141 topic
  11. SWI/SNF Complexes141 topic
  12. Cancer Immunotherapy111 topic
  13. Dendritic Cells111 topic
  14. Pim Oncogenes81 topic
  15. Tumorigenesis81 topic
  16. Activation51 topic
  17. Interferon Signaling51 topic
  18. Macrophage51 topic
  19. Viral Infection51 topic

Where does Wilfrid Richer work?

Wilfrid Richer's main affiliation in the publication record is Institut Curie, France.

How many publications and citations does Wilfrid Richer have?

OpenAlex counts 72 works and 3,548 citations for Wilfrid Richer, an h-index of 25, ranking #239,772 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Wilfrid Richer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.